4//SEC Filing
Lalwani Nikhil 4
Accession 0001822629-24-000014
CIK 0001023024other
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 5:38 PM ET
Size
10.4 KB
Accession
0001822629-24-000014
Insider Transaction Report
Form 4
Lalwani Nikhil
DirectorPRESIDENT & CEO
Transactions
- Sale
Common Stock
2024-11-26$57.95/sh−30,000$1,738,500→ 373,859 total - Exercise/Conversion
Stock Option (right to buy)
2024-11-26$29.00/sh−30,000$870,000→ 138,027 totalExercise: $29.00Exp: 2030-09-08→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2024-11-26$29.00/sh+30,000$870,000→ 403,859 total - Sale
Common Stock
2024-11-26$58.30/sh−3,481$202,942→ 370,378 total
Footnotes (3)
- [F1]The shares were sold in multiple trades at prices ranging from $57.76 to $58.55. The price reported above reflects the weighted average sales price.
- [F2]The shares were sold in multiple trades at prices ranging from $58.18 to $58.61. The price reported above reflects the weighted average sales price.
- [F3]25% of the total options vested on each of September 8, 2021, September 8, 2022, September 8, 2023 and September 8, 2024.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001822629
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 5:38 PM ET
- Size
- 10.4 KB